Biochip Implants for CoVid-19 Detection Profusa, in partnership with the U.S. Defense Advanced Research Projects Agency (DARPA), has created an injectable biosensor capable of detecting the presence of an infection in your body.
Injectable hydrogel biosensors are not rejected as foreign bodies like earlier implants, instead becoming one with your own tissue.
The technology consists of three components: the implanted sensor, a reader placed on the surface of the skin, and the software that allows the reader to send the collected data via Bluetooth to your phone or tablet, which in turn can be connected to other online sources such as your doctor’s website.
Profusa’s DARPA-backed technology will be able to detect the presence of flu-like infections including SARS-CoV-2 infections in the population before they become symptomatic. As such, the biosensors may become part of future pandemic detection systems.
Mass surveillance of biological data will require massively increased bandwidth in cellphone and Wi-Fi networks, and it’s possible that this is why governments are rushing implementation of 5G networks around the world without giving potentially adverse effects a second thought.